Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study

Applied Microbiology and Biotechnology

Volumn 100, Issue 10, 2016, Pages 4595-4605

  Salvetti, Elisa ^a,b   Orrù, Luigi ^c   Capozzi, Vittorio ^d   Martina, Alessia ^a   Lamontanara, Antonella ^c   Keller, David ^e   Cash, Howard ^e   Felis, Giovanna E ^a   Cattivelli, Luigi ^c   Torriani, Sandra ^a   Spano, Giuseppe ^d  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e Ganeden Biotech Inc   (United States)

Author keywords

Antibiotic resistance; Bacillus coagulans; Genomics; Probiotics; Safety; Virulence factors

Indexed keywords

ACCIDENT PREVENTION; AMINES; ANTIBIOTICS; BACTERIOLOGY; III-V SEMICONDUCTORS; RISK ASSESSMENT; SAFETY ENGINEERING; STRAIN;

ANTIBIOTIC RESISTANCE; BACILLUS COAGULANS; GENOMICS; PROBIOTICS; VIRULENCE FACTORS;

GENES;

AMPICILLIN; BIOGENIC AMINE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; LINEZOLID; NEOMYCIN; PROBIOTIC AGENT; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN; VIRGINIAMYCIN; VIRULENCE FACTOR; RNA 16S;

ACCURACY; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS COAGULANS; BACTERIAL GENOME; BACTERIAL STRAIN; BIOINFORMATICS; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC TRAIT; GENOME ANALYSIS; GENOMICS; METABOLITE; NONHUMAN; PHENOTYPE; SAFETY; TAXONOMIC IDENTIFICATION; WORKFLOW; DNA SEQUENCE; DRUG EFFECTS; GENETICS; METABOLISM; MULTIDRUG RESISTANCE; PRODUCT SAFETY;

BACILLUS COAGULANS; BIOGENIC AMINES; CONSUMER PRODUCT SAFETY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOME, BACTERIAL; KANAMYCIN; PHENOTYPE; PROBIOTICS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; STREPTOMYCIN;

EID: 84960080704     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-016-7416-9     Document Type: Article

References (81)

1. Adimpong DB, Sørensen KI, Thorsen L, Stuer-Lauridsen B, Abdelgadir WS, Nielsen DS, Derkx PMF, Jespersen L (2012) Antimicrobial susceptibility of Bacillus strains isolated from primary starters for African traditional bread production and characterization of the bacitracin operon and bacitracin biosynthesis. Appl Environ Microbiol 78:7903–7914. doi:10.1128/AEM.00730-12
2. Barbour A, Philip K (2014) Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects. PLoS One 9:e100541. doi:10.1371/journal.pone.0100541
3. Bennedsen M, Stuer-Lauridsen B, Danielsen M, Johansen E (2011) Screening for antimicrobial resistance genes and virulence factors via genome sequencing. Appl Environ Microbiol 77:2785–2787. doi:10.1128/AEM.02493-10
4. Benson KF, Redman KA, Carter SG, Keller D, Farmer S, Endres JR, Jensen GS (2012) Probiotic metabolites from Bacillus coagulans GanedenBC30™ support maturation of antigen-presenting cell in vitro. World J Gastroenterol 18:1875–1883. doi:10.3748/wjg.v18.i16.1875
5. Canchaya C, Proux C, Fournous G, Bruttin A, Brussow H (2003) Prophage genomics. Microbiol Mol Biol Rev 67:238–276. doi:10.1128/MMBR.67.2.238-276.2003
6. Chen LH, Xiong ZH, Sun LL, Yang J, Jin Q (2012) VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res 40:D641–D645. doi:10.1093/nar/gkr989
7. Chun J, Lee JH, Jung Y, Kim M, Kim S, Kim BK, Lim YM (2007) EzTaxon: a web-based tool for the identification of prokaryotes based on 16S ribosomal RNA gene sequences. Int J Syst Evol Microbiol 57:2259–2261. doi:10.1099/ijs.0.64915-0
8. Courvalin P (2006) Antibiotic resistance: the pros and cons of probiotics. Dig Liver Dis 38:S261–S265. doi:10.1016/S1590-8658(07)60006-1
9. Cutting SM (2011) Bacillus probiotics. Food Microbiol 28:214–220. doi:10.1016/j.fm.2010.03.007
10. Devirgiliis C, Barile S, Perozzi G (2011) Antibiotic resistance determinant in the interplay between food and gut microbiota. Genes Nutr 6:275–284. doi:10.1007/s12263-011-0226-x
11. Dolin BJ (2009) Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol 31:655–659. doi:10.1358/mf.2009.31.10.1441078
12. EFSA (2007) Opinion of the Scientific Committee. Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. EFSA J 587:1–16. doi:10.2903/j.efsa.2007.587
13. EFSA (2011) Scientific opinion. Technical guidance on the assessment of the toxinogenic potential of Bacillus species used in animal nutrition. EFSA J 9:2245. doi:10.2903/j.efsa.2011.2445
14. EFSA (2012) Scientific opinion. Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J 10:2740. doi:10.2903/j.efsa.2012.2740
15. EFSA (2013) Scientific opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2013 update). EFSA J 11:3449. doi:10.2903/j.efsa.2013.3449
16. EFSA (2014) Guidance on the assessment of the toxigenic potential of Bacillus species used in animal nutrition. EFSA J 12:3665. doi:10.2903/j.efsa.2014.3665
17. Ehling-Schulz M, Guinebretiére M-H, Monthán A, Berge O, Fricker M, Svensson B (2006) Toxin gene profiling of enterotoxic and emetic Bacillus cereus. FEMS Microbiol Lett 260:232–240. doi:10.1111/j.1574-6968.2006.00320.x
18. Endres JR, Clewell A, Jade KA, Farber T, Hauswirth J, Schauss AG (2009) Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 47:1231–1238. doi:10.1016/j.fct.2009.02.018
19. Endres JR, Qureshi I, Farber T, Hauswirth J, Hirka G, Pasics I, Schauss AG (2011) One-year chronic oral toxicity with combined reproduction toxicity study of a novel probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 49:1174–1182. doi:10.1016/j.fct.2011.02.012
20. European Commission (2003) Health & Consumer Protection Directorate-General. Opinion of the scientific committee on animal nutrition on the criteria for assessing the safety of micro-organisms resistant to antibiotics of human clinical and veterinary importance. ec.europa.eu/food/fs/sc/scan/out108_en.pdf
21. Felsenstein J (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783–791. doi:10.2307/2408678
22. Fitzpatrick LR, Smal JS, Green WH, Karpa KD, Farmer S, Keller D (2012) Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-induced colitis following vancomycin withdrawal in mice. Gut Pathog 4:13. doi:10.1186/1757-4749-4-13
23. Fitzpatrick LR, Small JS, Green WH, Karpa KD, Keller D (2011) Bacillus coagulans GBI-30 (BC30) improves indices of Clostridium difficile-induced colitis in mice. Gut Pathog 3:16. doi:10.1186/1757-4749-3-16
24. From C, Hormazabal V, Granum PE (2007a) Food poisoning associated with pumilacidin-producing Bacillus pumilus in rice. Int J Food Microbiol 115:319–324. doi:10.1016/j.ijfoodmicro.2006.11.005
25. From C, Hormazabal V, Hardy SP, Granum PE (2007b) Cytotoxicity in Bacillus mojavensis is abolished following loss of surfactin synthesis: implications for assessment of toxicity and food poisoning potential. Int J Food Microbiol 117:43–49. doi:10.1016/j.ijfoodmicro.2007.01.013
26. Ganeden Biotech, Inc. (2011) Notice to US Food and Drug Administration that Bacillus coagulans GBI-30, 6086, a Novel Probiotic, is generally recognized as safe for use in Foods http://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/UCM277775
27. Garrigues C, Johansen E, Crittenden R (2013) Pangenomics—an avenue to improved industrial starter cultures and probiotics. Curr Opin Biotechnol 24:187–191. doi:10.1016/j.copbio.2012.08.009
28. Green DH, Wakeley PR, Page A, Barnes A, Baccigalupi L, Ricca E, Cutting SM (1999) Characterization of two Bacillus probiotics. Appl Environ Microbiol 65:4288–4291
29. Grissa I, Vergnaud G, Pourcel C (2007) CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res 35:W52–W57. doi:10.1093/nar/gkm360
30. Guinebretière M-H, Broussolle V, Nguyen-The C (2002) Enterotoxigenic profiles of food-poisoning and food-borne Bacillus cereus strains. J Clin Microbiol 40:3053–3056. doi:10.1128/JCM.40.8.3053-3056.2002
31. Hanfrey CC, Pearson BM, Hazeldine S, Lee J, Gaskin DJ, Woster PM, Phillips MA, Michael AJ (2011) Alternative spermidine biosynthetic route is critical for growth of Campylobacter jejuni and is the dominant polyamine pathway in the human gut microbiota. J Biol Chem 286:43301–43312. doi:10.1074/jbc.M111.307835
32. Hill C, Sanders ME (2013) Rethinking probiotics. Gut Microbes 4:269–270. doi:10.4161/gmic.25143
33. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document. International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 8:506–514. doi:10.1038/nrgastro.2014.66
34. 30 (Bacillus coagulans GBI-30, 6086) supplementation on pathogen survival in the human gut microbiota. Anaerobe 17:36–42. doi:10.1016/j.anaerobe.2010.12.006
35. Hong HA, Duc le H, Cutting SM (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29:813–835. doi:10.1016/j.femsre.2004.12.001
36. Horvath P, Barrangou R (2010) CRISPR/Cas, the immune system of bacteria and archaea. Science 327:167–170. doi:10.1126/science.1179555
37. Hun L (2009) Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgrad Med 121:119–124. doi:10.3810/pgm.2009.03.1984
38. Hyronimus B, Le Marrec C, Sassi AH, Deschamps A (2000) Acid and bile tolerance of spore-forming lactic acid bacteria. Int J Food Microbiol 61:193–197. doi:10.1016/S0168-1605(00)00366-4
39. Jensen GS, Benson KF, Carter SG, Endres JR (2010) GanedenBC30™ cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro. BMC Immunol 11:15. doi:10.1186/1471-2172-11-15
40. Jolley KA, Bliss CM, Bennett JS, Bratcher HB, Brehony C, Colles FM, Wimalarathna H, Harrison OB, Sheppard SK, Cody AJ, Maiden MC (2012) Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain. Microbiology 158:1005–1015. doi:10.1099/mic.0.055459-0
41. Jurenka JS (2012) Bacillus coagulans. Altern Med Rev 17:76–81
42. Kalman DS, Schwartz HI, Alvarez P, Feldman S, Pezzullo JC, Krieger DR (2009) A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterol 9:85. doi:10.1186/1471-230X-9-85
43. Kopit LM, Kim EB, Siezen RJ, Harris LJ, Marco ML (2014) Safety of the surrogate microorganism Enterococcus faecium NRRL B-2354 for use in thermal process validation. Appl Environ Microbiol 80:1899–1909. doi:10.1128/AEM.03859-13
44. Kumar H, Salminen S, Verhagen H, Rowland I, Heimbach J, Bañares S, Young T, Nomot T, Lalonde M (2015) Novel probiotics and prebiotics: road to the market. Curr Opin Biotechnol 32:99–103. doi:10.1016/j.copbio.2014.11.021
45. Lee J, Sperandio V, Frantz DE, Longgood J, Camilli A, Phillips MA, Michael AJ (2009) An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in Vibrio cholerae. J Biol Chem 284:9899–9907. doi:10.1074/jbc.M900110200
46. Leuschner RGK, Robinson TP, Hugas M, Cocconcelli P, Richard-Forget F, Klein G, Licht TR, Nguyen-The C, Querol A, Richardson M, Suarez JE, Thrane U, Valk JM, von Wright A (2010) Qualified Presumption of Safety (QPS) is a generic risk assessment approach applied by the European Food Safety Authority (EFSA). Trends Food Sci Technol 21:425–435. doi:10.1016/j.tifs.2010.07.003
47. Liu S, Zhao L, Ren F, Sun E, Zhang M, Guo H (2015) Complete genome sequence of Bifidobacterium adolescentis BBMN23, a probiotic strain from healthy centenarian. J Biotechnol 198:44–45. doi:10.1016/j.jbiotec.2015.02.003
48. Maathuis AJH, Keller D, Farmer S (2010) Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine. Benef Microbes 1:31–36. doi:10.3920/BM2009.0009
49. Maraffini LA, Sontheimer EJ (2008) CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322:1843–1845. doi:10.1126/science.1165771
50. Martuscelli M, Crudele MA, Gardini F, Suzzi G (2000) Biogenic amine formation and oxidation by Staphylococcus xylosus strains from artisanal fermented sausages. Lett Appl Microbiol 31:228–232. doi:10.1046/j.1365-2672.2000.00796.x
51. McArthur AG, Waglechner N, NizamF YA, Azad MA, Baylay AJ, Bhullar K, Canova MJ, De Pascale G, Ejim L, Kalan L, King AM, Koteva K, Morar M, Mulvey MR, O’Brien JS, Pawlowski AC, Piddock LJ, Spanogiannopoulos P, Sutherland AD, Tang I, Taylor PL, Thaker M, Wang W, Yan M, Yu T, Wright GD (2013) The comprehensive antibiotic resistance database. Antimicrob Agents Chemother 57:3348–3357. doi:10.1128/AAC.00419-13
52. Miquel S, Beaumont M, Martín R, Langella P, Braesco V, Thomas M (2015) A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb Cell Factories 14:48. doi:10.1186/s12934-015-0229-1
53. Nyangale EP, Farmer S, Cash HA, Keller D, Chernoff D, Gibson GR (2015) Bacillus coagulans GBI-30, 6086 modulates Faecalibacterium prausnitzii in older men and women. J Nutr 145:1446–1452. doi:10.3945/jn.114.199802
54. Nyangale EP, Farmer S, Keller D, Chernoff D, Gibson RG (2014) Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086. Anaerobe 30:75–81. doi:10.1016/j.anaerobe.2014.09.002
55. Orrù L, Salvetti E, Cattivelli L, Lamontanara A, Michelotti V, Capozzi V, Spano G, Keller D, Cash H, Martina A, Torriani S, Felis GE (2014) Draft genome sequence of Bacillus coagulans GBI-30, 6086, a widely used spore-forming probiotic strain. Genome Announc 2:e01080–e01014. doi:10.1128/genomeA.01080-14
56. Poehlsgaard J, Douthwaite S (2005) The bacterial ribosome as a target for antibiotics. Nat Rev Microbiol 3:870–881. doi:10.1038/nrmicro1265
57. Poretsky R, Rodriguez-R LM, Luo C, Tsementzi D, Konstantinidis KT (2014) Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. PLoS One 9:e93827. doi:10.1371/journal.pone.0093827
58. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425
59. Salkinoja-Salonen MS, Vuorio R, Andersson MA, Kamfer P, Andersson MC, Honkanen-Buzalski T, Scoging AC (1999) Toxigenic strains of Bacillus licheniformis related to food poisoning. Appl Environ Microbiol 65:4637–4645
60. Salvetti E, Torriani S, Felis GE (2015) A survey on established and novel probiotic strains for probiotic applications. In: Foerst P, Santivarangkna C (ed). Advances in probiotic technology. CRC Press, pp. 26–44
61. Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Hormannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, Phothirath P, Solano-Aguilar G, Vaughan E (2010) Safety assessment of probiotics for human use. Gut Microbes 1:164–185. doi:10.4161/gmic.1.3.12127
62. Sanders ME, Klaenhammer TR, Ouwehand AC, Pot B, Johansen HJT, Marco ML, Tennilä RRP, Franz C, Pagé N, Pridmore RD, Leyer G, Salminen S, Charbonneau D, Call E, Lenoir-Wijnkoop I (2014) Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Ann N Y Acad Sci 1309:1–18. doi:10.1111/nyas.12363
63. Sanders ME, Morelli L, Tompkins TA (2003) Sporeformers as human probiotics: Bacillus, Sporolactobacillus and Brevibacillus. Compr Rev Food Sci Food Saf 2:101–110. doi:10.1111/j.1541-4337.2003.tb00017.x
64. Senan S, Prajapati JB, Joshi CG (2015) Feasibility of genome-wide screening for biosafety assessment of probiotics: a case study of Lactobacillus helveticus MTCC 5463. Probiotics Antimicro Proteins 7:249–258. doi:10.1007/s12602-015-9199-1
65. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using ClustalOmega. Mol Syst Biol 7:539. doi:10.1038/msb.2011.75
66. Stenfors-Arnesen LP, Fagerlund A, Granum PE (2008) From soil to gut: Bacillus cereus and its food poisoning toxins. FEMS Microbiol Rev 32:579–606. doi:10.1111/j.1574-6976.2008.00112.x
67. T, a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing. Food Chem Toxicol 72:129–137. doi:10.1016/j.fct.2014.06.024
68. Sun E, Zhao L, Ren F, Liu S, Zhang M, Guo H (2015) Complete genome sequence of Bifidobacterium animalis subsp. lactis A6, a probiotic strain with high acid resistance ability. J Biotechnol 200:8–9. doi:10.1016/j.jbiotec.2015.02.016
69. Tabanelli G, Montanari C, Bargossi E, Lanciotti R, Gatto V, Felis G, Torriani S, Gardini F (2014) Control of tyramine and histamine accumulation by lactic acid bacteria using bacteriocin forming lactococci. Int J Food Microbiol 190:14–23. doi:10.1016/j.ijfoodmicro.2014.08.023
70. Tabanelli G, Torriani S, Rossi F, Rizzotti L, Gardini F (2012) Effect of chemico-physical parameters on the histidine decarboxylase (HdcA) enzymatic activity in Streptococcus thermophilus PRI60. J Food Sci 77:M231–M237. doi:10.1111/j.1750-3841.2012.02628.x
71. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30:2725–2729. doi:10.1093/molbev/mst197
72. Tapi A, Chollet-Imbert M, Scherens B, Jacques P (2010) New approach for the detection of non-ribosomal peptide synthetase genes in Bacillus strains by polymerase chain reaction. Appl Microbiol Biotechnol 85:1521–1531. doi:10.1007/s00253-009-2176-4
73. Van Hoek AHAM, Mevius D, Guerra B, Mullany P, Roberts AP, Aarts HJM (2011) Acquired antibiotic resistance genes: an overview. Front Microbiol 2:203. doi:10.3389/fmicb.2011.00203
74. Van Loveren H, Sanz Y, Salminen S (2012) Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Food Sci Technol 3:247–261. doi:10.1146/annurev-food-022811-101206
75. Van Reenen CA, Dicks LM (2011) Horizontal gene transfer amongst probiotic lactic acid bacteria and other intestinal microbiota: what are the possibilities? A review. Arch Microbiol 193:157–168. doi:10.1007/s00203-010-0668-3
76. Vankerckhoven V, Huys G, Vancanneyt M, Vael C, Klare I, Romond M-B, Entenza J, Moreillon P, Wind R, Knol J, Wiertz E, Pot B, Vaughan EE, Kahlmeter G, Goossens H (2008) Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trends Food Sci Technol 19:102–114. doi:10.1016/j.tifs.2007.07.013
77. Wassenaar TM, Zschüttig A, Beimfohr C, Geske T, Auerbach C, Cook H, Zimmermann K, Gunzer F (2015) Virulence genes in a probiotic E. coli product with a recorded long history of safe use. Eur J Microbiol Immunol (Bp) 5:81–93. doi:10.1556/EUJMI-D-14-00039
78. Wei Y-X, Zhang Z-Y, Liu C, Malakar PK, Guo X-K (2012) Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences. World J Gastroenterol 18:479–488. doi:10.3748/wjg.v18.i5.479
79. Yakimov MM, Kröger A, Slepack TN, Giuliano L, Timmis KN, Golyshin PN (1998) A putative lichenysin A synthetase operon in Bacillus licheniformis: initial characterization. Biochim Biophys Acta 1399:141–153. doi:10.1016/S0167-4781(98)00096-7
80. Zhang Z-Y, Liu C, Zhu Y-Z, Wei Y-X, Tian F, Zhao G-P, Guo X-K (2012) Safety assessment of Lactobacillus plantarum JDM1 based on the complete genome. Int J Food Microbiol 153:166–170. doi:10.1016/j.ijfoodmicro.2011.11.003
81. Zuo F, Yu R, Khaskheli GB, Ma H, Chen L, Zeng Z, Mao A, Chen S (2014) Homologous overexpression of alkyl hydroperoxide reductase subunit C (ahpC) protects Bifidobacterium longum strain NCC2705 from oxidative stress. Res Microbiol 165:581–589. doi:10.1016/j.resmic.2014.05.040